Buscador de Publicaciones

Metastatic pancreatic and lung cancer patient in complete remission following immunotherapy: A case report and review of literature

Autores: Martínez-Galán, J; Jiménez-Luna, C; Rodriguez, I; Maza, E; García-Collado, C; Rodríguez-Fernández, A; López-Hidalgo, JL; Caba, O

SEOM-GEMCAD-TTD clinical guidelines for the adjuvant treatment of colon cancer (2023)

Autores: Pericay, C; Montagut, C; Reina, JJ; Melian, M; Alcaide, J; Tarazona, N; Ruiz-Casado, A; González-Flores, E; Graña, B; Grávalos, C

Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial

Autores: García-Alfonso, P; Elez, E; Soto-Alsar, J; Páez, D; Fernández-Montes, A; Graña, B; Salud, A; Yubero, A; Gómez-España, MA; Macías, I; Quintero, G; López-López, C; Fernández-Rodríguez, T; Grávalos, C; González-Flores, E; Guix, M; Paredes, BG; Reina, JJ; Mowbray, JRR; Sastre, J; Aranda, E

Recommendations for the management of yttrium-90 radioembolization in the treatment of patients with colorectal cancer liver metastases: a multidisciplinary review

Autores: González-Flores, E; Zambudio, N; Pardo-Moreno, P; Gonzalez-Astorga, B; de la Rúa, JR; Triviño-Ibáñez, EM; Navarro, P; Espinoza-Cámac, N; Casado, MA; Rodríguez-Fernández, A

Role of Single-Nucleotide Polymorphisms in Genes Implicated in Capecitabine Pharmacodynamics on the Effectiveness of Adjuvant Therapy in Colorectal Cancer

Autores: Cura, Y; Sánchez-Martín, A; Márquez-Pete, N; González-Flores, E; Martínez-Martínez, F; Pérez-Ramírez, C; Jiménez-Morales, A

Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study

Autores: Romero-Laorden, N; Lorente, D; de Velasco, G; Lozano, R; Herrera, B; Puente, J; López, PP; Medina, A; Almagro, E; Gonzalez-Billalabeitia, E; Villla-Guzman, JC; González-del-Alba, A; Borrega, P; Laínez, N; Fernández-Freire, A; Hernández, A; Rodriguez-Vida, A; Chirivella, I; Fernandez-Parra, E; López-Campos, F; Pacheco, MI; Morales-Barrera, R; Fernández, O; Villatoro, R; Luque, R; Hernando, S; Castellano, DC; Castro, E; Olmos, D

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial

Autores: Siefker-Radtke, AO; Matsubara, N; Park, SH; Huddart, RA; Burgess, EF; Özgüroglu, M; Valderrama, BP; Laguerre, B; Basso, U; Triantos, S; Akapame, S; Kean, Y; Deprince, K; Mukhopadhyay, S; Loriot, Y

< 1 2 … 183 184 185 … 1.504 1.505 >